• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    7.360 +0.710 (+10.68%)
    Streaming Delayed Price Updated: 3:05 PM EDT, Aug 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,485,085
    Open 6.870
    Bid (Size) 7.350 (200)
    Ask (Size) 7.370 (700)
    Prev. Close 6.650
    Today's Range 6.590 - 7.590
    52wk Range 2.960 - 40.37
    Shares Outstanding 45,711,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 17, 2026) - Kahn Swick & Foti, LLC ("KSF")... 
    Via Newsfile
    Topics Lawsuit
    News headline image
    Kaplan Fox Advises Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Act Before the Lead Plaintiff Deadline on September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire

    Performance

    YTD
    -74.0%
    -74.0%
    1 Month
    -62.1%
    -62.1%
    3 Month
    -73.7%
    -73.7%
    6 Month
    -68.0%
    -68.0%
    1 Year
    -4.4%
    -4.4%

    More News

    Read More
    News headline image
    Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Deadline Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Have Until September 28, 2026 to Seek a Lead Plaintiff Role
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    News headline image
    Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) – Lead Plaintiff Deadline is September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    Friday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Capricor Therapeutics Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Capricor Therapeutics Q2 2026 Earnings Call Transcript ↗
    Via Benzinga
    Topics Earnings
    News headline image
    Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    News headline image
    Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 7.360
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 08/17/26 03:05 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 336.44M
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 336M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.